Skip to main content

Table 1 Clinical and tumor characteristics of the LUAD cohorts

From: Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma

  TCGA cohort GEO cohort
No. of patients 316 381
Age (median, range) 64 (33–86) 69 (38–89)
Gender
 Female 163 (51.6%) 166 (43.6%)
 Male 153 (48.4%) 215 (56.4%)
Tumor
 T 1–2 275 (87.0%) NA
 T 3–4 41 (13.0%) NA
Node
N 0–1 267 (84.5%) NA
N 2–3 49 (15.5%) NA
Metastasis
M 0 296 (93.7%) NA
M 1 20 (6.3%) NA
TNM stage
 I 164 (51.9%) 246 (64.6%)
 II 76 (24.1%) 65 (17.1%)
 III 56 (17.7%) 56 (14.7%)
 IV 20 (6.3%) 14 (3.6%)
TP53
 Wide type NA 287 (75.3%)
 Mutant type NA 94 (24.7%)
Survival status
 OS years (median) 2.19 2.24
  1. LUAD adenocarcinoma of lung, TCGA The Cancer Genome Atlas, GEO Gene Expression Omnibus, No number, T tumor, N regional lymph node, M metastasis, NA not available, OS overall survival